Shadowfax Technologies Allots Equity Shares Under ESOP Plan, Increasing Paid-Up Capital
Shadowfax Technologies Ltd has increased its issued capital following the allotment of equity shares to eligible employees and ESOP holders under the Shadowfax Technologies Limited - Employee Stock Option Plan 2016 (SFX ESOP 2016). The Board of Directors approved the allotment of 1,241,478 equity shares, each having a face value of Rs. 10/-.The stock options were exercised by eligible employees and ESOP holders as part of the SFX ESOP 2016 initiative.
This exercise has resulted in an increase in the company's issued, subscribed, and paid-up equity share capital. The capital stood previously at Rs. 5,85,31,97,500, comprising 58,53,19,750 equity shares of Rs. 10/- each.
Following the allotment, the total paid-up capital increased to Rs. 5,86,56,12,280, which corresponds to a total of 58,65,61,228 equity shares of Rs. 10/- each.
The transaction details and key financial metrics related to the ESOP exercise are as follows:
| Financial Metric | Detail |
|---|---|
| Total Shares Allotted | 1,241,478 equity shares |
| Face Value per Share | Rs. 10/- |
| Money Realized from Option Exercise | Rs. 1,24,14,780/ |
| Basic EPS (Year Ended March 31, 2026) | Rs. 2.22/- |
| Diluted EPS (Year Ended March 31, 2026) | Rs. 2.18/- |
The allotted shares are intended to rank pari passu in all respects with and carry the same rights as existing fully paid equity shares of Shadowfax Technologies Limited.
SHADOWFAX Stock Price Movement
As of 2:02 PM, shares of Shadowfax Technologies Limited rally upward in live trading, currently priced at ₹252.27 after gaining 1.91%. The stock sees significant activity in the market as it trades amidst a heavy volume exceeding 4.8 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.